Oestradiol assays: Fitness for purpose?

Annals of Clinical Biochemistry

Volumn 46, Issue 6, 2009, Pages 441-456

  Middle, Jonathan G ^a   Kane, John W ^b  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

17 HYDROXYPREGNENOLONE; 18 HYDROXYCORTICOSTERONE; ALDOSTERONE; ANDROSTANEDIOL; ANDROSTANOLONE; ANDROSTENEDIONE; CHOLESTEROL; CONJUGATED ESTROGEN; CORTICOSTERONE; CORTISONE; CORTODOXONE; DEOXYCORTICOSTERONE; ESTRADIOL; FOLLITROPIN; GONADORELIN; HYDROCORTISONE; HYDROXYPROGESTERONE; LUTEINIZING HORMONE; PRASTERONE; PREGNENOLONE; PROGESTERONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

AMENORRHEA; ANALYTIC METHOD; CLIMACTERIUM; CONCEPTION; ESTROGEN EXCRETION; ESTROGEN METABOLISM; ESTROGEN RELEASE; ESTROGEN SYNTHESIS; FEMALE FERTILITY; FERTILIZATION IN VITRO; GOVERNMENT; GYNECOMASTIA; HORMONE SUBSTITUTION; HUMAN; IMMUNOASSAY; MENOPAUSE; OLIGOMENORRHEA; ORGANIZATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ADOLESCENT; ADULT; CHEMISTRY, CLINICAL; CHILD; CHROMATOGRAPHY, GAS; ESTRADIOL; FEMALE; GREAT BRITAIN; HUMANS; MALE; MASS SPECTROMETRY; REGRESSION ANALYSIS; REPRODUCTIVE TECHNIQUES, ASSISTED; SIGNAL TRANSDUCTION;

EID: 73449111922     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/acb.2009.009102     Document Type: Review

References (29)

1. Gruber CJ, Tschugguel W, Schneeberger C, Huber JC. Production and actions of estrogens. N Engl J Med 2002;346:340-52
2. Ismail AAA, Barth JH. Endocrinology of gynaecomastia. Ann Clin Biochem 2001;38:596-607
3. Ratcliffe WA, Carter GD, Dowsett M, Hillier SG, Middle JG, Reed MJ. Oestradiol assays: applications and guidelines for the provision of a clinical biochemistry service. Ann Clin Biochem 1988;25:466-83
4. Ruggiero RJ, Likis FE. Estrogen: physiology, pharmacology, and formulations for replacement therapy. J Midwifery Womens Health 2002;47:130-8
5. Pardridge WM. Serum bioavaiability of sex steroid hormones. Clin Endocrinol Metab 1986;15:259-78
6. Ekins R. The free hormone hypothesis and measurement of free hormones. Clin Chem 1992;38:1289-93
7. Simpson ER, Misso M, Hewitt KN, et al. Estrogen - the good, the bad, and the unexpected. Endocr Rev 2005;26:322-30
8. Warner M, Nilsson S, Gustafsson JA. The estrogen receptor family. Curr Opin Obstet Gynecol 1999;11:249-54
9. Jordan VC. Designer estrogens. Sci Am 1998;279:60-7
10. Ruder HJ, Loriaux L, Lipsett MB. Estrone sulphate: production rate and metabolism in man. J Clin Invest 1972;51:1020-33
11. Oakey RE, Holder G. The measurement of oestrogens. In: Makin HLJ, Gower DB, Kirk DN eds. Steroid Analysis, 1st edn. Chapman & Hall, Glasgow, 1995:427-67, ISBN 0 7514 0128 5
12. Barnard G, Kohen F. Idiometric assay: noncompetitive immunoassay for small molecules typified by the measurement of estradiol in serum. Clin Chem 1990;36:1945-50
13. Lee JS, Ettinger B, Stanczyk FZ, et al. Comparison of methods to measure low serum estradiol levels in postmenopausal women. Clin Endocrinol Metab 2006;91:3791-7
14. Siekmann L. Determination of steroid hormones by the use of isotope dilution - mass spectrometry: a definitive method in clinical chemistry. J Steroid Biochem 1979;11:117-23
15. Thienpont L. Meeting report: first and second Estradiol International Workshops. Clin Chem 1996;42:1122-4
16. Thienpont LM. Quality specifications for reference methods. Scand J Clin Lab Invest 1999;59:535-8
17. JCTLM website. See http://www.bipm.org/en/committees/jc/jctlm/ (last checked 20 January 2008)
18. Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices (1998-12-07 OJ No L 331/1)
19. Klein KO, Baron J, Colli MJ, McDonnell DP, Cutler GB. Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay. J Clin Invest 1994;94:2475-80
20. Klein KO, Demers LM, Santner SJ, Baron J, Cutler GB, Santen RJ. Use of ultrasensitive recombinant cell bioassay to measure estrogen levels in women with breast cancer receiving the aromatase inhibitor, Letrozole. J Clin Endo Metab 1995;80:2658-60
21. Forti G, Krausz C. Evaluation and treatment of the infertile couple. J Clin Endo Metab 1998;83:4177-88
22. Evers J. Female subfertility. Lancet 2002;360:151-9
23. Norman RJ. Clinical chemistry and the new assisted reproductive technologies. Clin Biochem Rev 1997;18:3-10
24. Gow SM, Turner EI, Glaiser A. The clinical biochemistry of the menopause and hormone replacement therapy. Ann Clin Biochem 1994;31:509-28
25. Armston A, Wood P. Hormone replacement therapy (oestradiol only preparations): can the laboratory recommend a concentration of plasma oestradiol to protect against osteoporosis. Ann Clin Biochem 2002;39:184-93
26. Buckler HM, Kalor PK, Cantrill JA, Anderson DC. An audit of oestradiol levels and implant frequency in women undergoing subcutaneous implant therapy. Clin Endocrinol 1995;42:445-50
27. Gosling JP, Middle J, Siekmann L, Read G. Standardization of hapten immunoprocedures: total cortisol. Scand J Clin Lab Invest 1993;53(suppl 216):3-41
28. Nelson RE, Grebe SK, OKane DJ, Singh RJ. Liquid chromatographytandem mass spectrometry assay for simultaneous measurement of estradiol and estrone in human plasma. Clin Chem 2004;50:373-84
29. Kushnir MM, Rockwood AL, Bergquist J, et al. High-sensitivity tandem mass spectrometry assay for serum estrone and estradiol. Am J Clin Pathol. 2009;131:746-7